JPS6272620A - 播種性血管内凝固症候群予防・治療剤 - Google Patents

播種性血管内凝固症候群予防・治療剤

Info

Publication number
JPS6272620A
JPS6272620A JP60211377A JP21137785A JPS6272620A JP S6272620 A JPS6272620 A JP S6272620A JP 60211377 A JP60211377 A JP 60211377A JP 21137785 A JP21137785 A JP 21137785A JP S6272620 A JPS6272620 A JP S6272620A
Authority
JP
Japan
Prior art keywords
preventive
dic
lentinan
present
disseminating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP60211377A
Other languages
English (en)
Japanese (ja)
Other versions
JPH0362698B2 (enExample
Inventor
Jiro Tsubouchi
坪内　二郎
Mutsumi Kazama
風間　睦美
Hidemi Ishii
秀美 石井
Denichi Mizuno
水野　伝一
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Japan Science and Technology Agency
Original Assignee
Research Development Corp of Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Research Development Corp of Japan filed Critical Research Development Corp of Japan
Priority to JP60211377A priority Critical patent/JPS6272620A/ja
Publication of JPS6272620A publication Critical patent/JPS6272620A/ja
Publication of JPH0362698B2 publication Critical patent/JPH0362698B2/ja
Granted legal-status Critical Current

Links

Classifications

    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
JP60211377A 1985-09-25 1985-09-25 播種性血管内凝固症候群予防・治療剤 Granted JPS6272620A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP60211377A JPS6272620A (ja) 1985-09-25 1985-09-25 播種性血管内凝固症候群予防・治療剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP60211377A JPS6272620A (ja) 1985-09-25 1985-09-25 播種性血管内凝固症候群予防・治療剤

Publications (2)

Publication Number Publication Date
JPS6272620A true JPS6272620A (ja) 1987-04-03
JPH0362698B2 JPH0362698B2 (enExample) 1991-09-26

Family

ID=16604953

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60211377A Granted JPS6272620A (ja) 1985-09-25 1985-09-25 播種性血管内凝固症候群予防・治療剤

Country Status (1)

Country Link
JP (1) JPS6272620A (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005034974A1 (ja) * 2003-10-09 2005-04-21 Nihon University 血栓症の予防または改善のための健康食品及び血栓症の予防または治療用医薬組成物
CN103110576A (zh) * 2013-03-11 2013-05-22 河北凯盛医药科技有限公司 一种香菇多糖注射液制剂及其制备方法

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005034974A1 (ja) * 2003-10-09 2005-04-21 Nihon University 血栓症の予防または改善のための健康食品及び血栓症の予防または治療用医薬組成物
JP4877664B2 (ja) * 2003-10-09 2012-02-15 学校法人日本大学 血栓症の予防または改善のための健康食品及び血栓症の予防または治療用医薬組成物
CN103110576A (zh) * 2013-03-11 2013-05-22 河北凯盛医药科技有限公司 一种香菇多糖注射液制剂及其制备方法

Also Published As

Publication number Publication date
JPH0362698B2 (enExample) 1991-09-26

Similar Documents

Publication Publication Date Title
Page Treatment of essential and malignant hypertension
Finch et al. Iron nutrition and the fortification of food with iron
Wang et al. Clinical effects of continuous high volume hemofiltration on severe acute pancreatitis complicated with multiple organ dysfunction syndrome
JPS6169722A (ja) 医薬用組成物
Pollock Clinical experience with warfarin (coumadin) sodium, a new anticoagulant
Oram et al. Digitalis as a cause of paroxysmal atrial tachycardia with atrioventricular block
JPS6272620A (ja) 播種性血管内凝固症候群予防・治療剤
Gilchrist Coronary thrombosis and its response to treatment
JPH06507381A (ja) 熱性疾患の処置のための医薬品としてのプロスタサイクリン−およびカルバサイクリン誘導体
CA2195863C (en) Therapeutic drug for endotoxin blood symptom and multi-organ failure induced thereby
JP3769045B2 (ja) 抗炎症剤
AU3276399A (en) Remedies for aids
JP2596970B2 (ja) 白血球の粘着又は凝集抑制剤
JPS6289624A (ja) 播種性血管内凝固症候群予防・治療剤
EP1248638B1 (fr) Utilisation de l'enoxaparine pour le traitement de l'ischemie cerebrale
KR20020031404A (ko) 혈장 대체 조성물
JPS61171424A (ja) 脳圧下降剤
Dawber et al. Prevention of myocardial infarction
JPS6272613A (ja) 播種性血管内凝固症候群予防・治療剤
JPS6045529A (ja) 抗血栓症剤
Evans Anaemia associated with the sickle cell trait in British West African natives
Mantero et al. Effect of atenolol and metoprolol on the anticoagulant activity of acenocoumarin.
Chandler et al. Benign duodeno-colonic Fistula
JPS6213325B2 (enExample)
CN116407557A (zh) 一种防治出血性脑卒中的药物组合物及其应用